Emily Hays
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Cancer-related Molecular Pathways
Papers in
- Oncology 8
- Cancer-related Molecular Pathways 4
- Cancer Immunotherapy and Biomarkers 3
- Bone health and treatments 2
-
- Cancer, Hypoxia, and Metabolism 2
- Co-authors
- Benjamin Bonavida (3 shared papers)Nalini Chandar (5 shared papers)Hankui Chen (3 shared papers)Renier Vélez-Cruz (2 shared papers)Sophie La Salle (1 shared paper)Caitlin Carter (1 shared paper)V. Daniel (1 shared paper)Yuhao Wang (1 shared paper)
- Journals
- Biochemical and Biophysical Research Communications (1 paper)Experimental Cell Research (1 paper)Drug Resistance Updates (1 paper)Antioxidants (1 paper)Calcified Tissue International (1 paper)
- Partner nations
- United States
In The Last Decade
Emily Hays
12 papers receiving 329 citations
Peers
Comparison fields: 5 of 60
- Cancer Research 58
- Oncology 98
- Immunology 70
- Molecular Biology 169
- Pathology and Forensic Medicine 34
Countries citing papers authored by Emily Hays
This map shows the geographic impact of Emily Hays's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Hays with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Hays more than expected).
Fields of papers citing papers by Emily Hays
This network shows the impact of papers produced by Emily Hays. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Hays. The network helps show where Emily Hays may publish in the future.
Co-authors
The 15 scholars most cited alongside Emily Hays, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 121 | |
| 2 | 2019 | 51 | |
| 3 | 2020 | 29 | |
| 4 | 2017 | 26 | |
| 5 | 2006 | 21 | |
| 6 | 2012 | 21 | |
| 7 | 2012 | 18 | |
| 8 | 2019 | 14 | |
| 9 | 2022 | 13 | |
| 10 | 2011 | 10 | |
| 11 | 2009 | 6 | |
| 12 | 2013 | 4 |
About Emily Hays
Emily Hays is a scholar working on Oncology, Cancer Research, Immunology, Molecular Biology and Psychiatry and Mental health, having authored 12 papers that have together received 334 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Immune Cell Function and Interaction (2 papers), DNA Repair Mechanisms (2 papers), Immunotherapy and Immune Responses (2 papers), Chromatin Remodeling and Cancer (2 papers), Bone health and treatments (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Cancer Research (58 citations), Oncology (98 citations), Immunology (70 citations), Molecular Biology (169 citations) and Pathology and Forensic Medicine (34 citations). Emily Hays has collaborated with scholars based in United States. Frequent co-authors include Benjamin Bonavida, Nalini Chandar, Hankui Chen, Renier Vélez-Cruz, Sophie La Salle, Caitlin Carter, V. Daniel, Yuhao Wang, Stephen Eck and Ivan M. Tomek. Their work appears in journals such as Biochemical and Biophysical Research Communications, Experimental Cell Research, Drug Resistance Updates, Antioxidants and Calcified Tissue International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.